EPIME
PFE icon

Evelyn Partners Investment Management (Europe)’s Pfizer PFE Stock Holding History

Evelyn Partners Investment Management (Europe)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-625
Closed -$15.6K – 188
2025
Q4 		$15.6K Hold
625
– – 0.01% 164
2025
Q3 		$15.9K Hold
625
– – 0.01% 157
2025
Q2 		$15.2K Hold
625
– – 0.01% 160
2025
Q1 		$15.8K Hold
625
– – 0.01% 158
2024
Q4 		$16.6K Buy
+625
New +$17K 0.01% 159

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Evelyn Partners Investment Management (Europe)'s PFE Position: Q1 2026 in Review

Evelyn Partners Investment Management (Europe) sold out of Pfizer (PFE) in Q1 2026, closing a stake of 625 shares — an estimated $15.6K sold.

Evelyn Partners Investment Management (Europe) first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $16.6K in Q4 2024. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Evelyn Partners Investment Management (Europe) reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Evelyn Partners Investment Management (Europe) sold 625 Pfizer shares in Q1 2026, an estimated $15.6K.
  • Evelyn Partners Investment Management (Europe) first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
  • Evelyn Partners Investment Management (Europe)'s Pfizer position peaked at $16.6K in Q4 2024.
  • 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Evelyn Partners Investment Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.